Reply to Weigang Yan, Zhien Zhou, Hanzhong Li's Letter to the Editor re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81

Affiliations

¹ The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
² The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address: mmamawa1@jhmi.edu.

Comment

Jeffery J Tosoian et al. Eur Urol. 2017 Jan.

. 2017 Jan;71(1):e13.

doi: 10.1016/j.eururo.2016.05.037. Epub 2016 Jun 13.

¹ The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
² The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address: mmamawa1@jhmi.edu.

No abstract available

Comment on

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery.
Tosoian JJ, Sundi D, Trock BJ, Landis P, Epstein JI, Schaeffer EM, Carter HB, Mamawala M. Tosoian JJ, et al. Eur Urol. 2016 Apr;69(4):576-581. doi: 10.1016/j.eururo.2015.09.032. Epub 2015 Oct 9. Eur Urol. 2016. PMID: 26456680
Re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81.
Yan W, Zhou Z, Li H. Yan W, et al. Eur Urol. 2017 Jan;71(1):e12. doi: 10.1016/j.eururo.2016.05.036. Epub 2016 Jun 1. Eur Urol. 2017. PMID: 27262630 No abstract available.